Methylation of TFPI2 in stool DNA: A potential novel biomarker for the detection of colorectal cancer

Cancer Research

Volumn 69, Issue 11, 2009, Pages 4691-4699

  Glöckner, Sabine C ^a,f   Dhir, Mashaal ^a   Joo, Mi Yi ^b   McGarvey, Kelly E ^b   Van Neste, Leander ^c   Louwagie, Joost ^d   Chan, Timothy A ^e   Kleeberger, Wolfram ^b,f   De Bruïne, Adriaan P ^g   Smits, Kim M ^g   Khalid de Bakker, Carolina A J ^h   Jonkers, Daisy M A E ^h   Stockbrügger, Reinhold W ^h   Meijer, Gerrit A ⁱ   Oort, Frank A ⁱ   Iacobuzio Donahue, Christine ^a   Bierau, Katja ^d   Herman, James G ^b   Baylin, Stephen B ^b   Van Engeland, Manon ^g   Schuebel, Kornel E ^b   Ahuja, Nita ^a,b,j   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c GHENT UNIVERSITY   (Belgium)

^d OncoMethylome Sciences SA   (Belgium)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY OF REGENSBURG   (Germany)

^g MAASTRICHT UNIVERSITY   (Netherlands)

^h MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^j DEPARTMENT OF PATHOLOGY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER DIAGNOSIS; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DNA DETERMINATION; DNA METHYLATION; EARLY CANCER; EARLY DIAGNOSIS; FECES; FEMALE; GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TFPI2 GENE;

AGED; AGED, 80 AND OVER; ALGORITHMS; CACO-2 CELLS; CARCINOMA; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; EARLY DETECTION OF CANCER; FECES; FEMALE; GLYCOPROTEINS; HCT116 CELLS; HT29 CELLS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 66349102768     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-0142     Document Type: Article

References (39)

1. Ohm JE, Baylin SB. Stem cell chromatin patterns: an instructive mechanism for DNA hypermethylation? Cell Cycle 2007;6:1040-1043
2. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007;128:683-692 (Pubitemid 46273572)
3. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042-2054 (Pubitemid 37448928)
4. Shames DS, Minna JD, Gazdar AF. DNA methylation in health, disease, and cancer. Curr Mol Med 2007;7:85-102. (Pubitemid 46322281)
5. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
6. Heresbach D, Manfredi S, D'Halluin PN, Bretagne JF, Branger B. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test. Eur J Gastroenterol Hepatol 2006;18:427-433
7. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 2006;15:389-394 (Pubitemid 43342192)
8. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130-160
9. Osborn NK, Ahlquist DA. Stool screening for colorectal cancer: molecular approaches. Gastroenterology 2005;128:192-206. (Pubitemid 40039970)
10. Ahlquist DA, Sargent DJ, Loprinzi CL, et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008;149:441-50, W481.
11. Schuebel KE, Chen W, Cope L, et al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 2007;3:1709-1723 (Pubitemid 47510263)
12. Ohm JE, McGarvey KM, Yu X, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007;39:237-242 (Pubitemid 46184356)
13. Widschwendter M, Fiegl H, Egle D, et al. Epigenetic stem cell signature in cancer. Nat Genet 2007;39:157-158 (Pubitemid 46184343)
14. Sparmann A, van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 2006;6:846-856 (Pubitemid 44629896)
15. Bernstein BE, Mikkelsen TS, Xie X, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006;125:315-326
16. Wong CM, Ng YL, Lee JM, et al. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. Hepatology 2007;45:1129-1138 (Pubitemid 46775774)
17. Sato N, Parker AR, Fukushima N, et al. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. Oncogene 2005;24:850-858 (Pubitemid 40216093)
18. McGarvey KM, Van Neste L, Cope L, et al. Defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells. Cancer Res 2008;68:5753-5759
19. Kim MS, Chang X, Nagpal JK, et al. The N-methyl-D-aspartate receptor type 2A is frequently methylated in human colorectal carcinoma and suppresses cell growth. Oncogene 2008;27:2045-2054
20. van Engeland M, Weijenberg MP, Roemen GM, et al. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands Cohort Study on Diet and Cancer. Cancer Res 2003;63:3133-3137 (Pubitemid 36735864)
21. Janes H, Pepe MS. Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting. Am J Epidemiol 2008;168:89-97.
22. Barski A, Cuddapah S, Cui K, et al. High-resolution profiling of histone methylations in the human genome. Cell 2007;129:823-837 (Pubitemid 46802390)
23. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 2006;20:1123-1136
24. Mikkelsen TS, Ku M, Jaffe DB, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007;448:553-560 (Pubitemid 47206934)
25. Nobeyama Y, Okochi-Takada E, Furuta J, et al. Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas. Int J Cancer 2007;121:301-307 (Pubitemid 46917698)
26. Rollin J, Iochmann S, Blechet C, et al. Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer. Br J Cancer 2005;92:775-783 (Pubitemid 40460617)
27. Shames DS, Girard L, Gao B, et al. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med 2006;3:e486. (Pubitemid 46028510)
28. Sova P, Feng Q, Geiss G, et al. Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis. Cancer Epidemiol Biomarkers Prev 2006;15:114-123
29. Mixich F, Ioana M, Voinea F, Saftoiu A, Ciurea T. Noninvasive detection through REMS-PCR technique of K-ras mutations in stool DNA of patients with colorectal cancer. J Gastrointestin Liver Dis 2007;16:5-10. (Pubitemid 46548583)
30. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-2714 (Pubitemid 39665324)
31. Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007;318:1108-1113 (Pubitemid 350134889)
32. Diehl F, Schmidt K, Durkee KH, et al. Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients. Gastroenterology 2008;135:489-498
33. Chen WD, Han ZJ, Skoletsky J, et al. Detection in fecal DNA of colon cancer-specific methylation of the non-expressed vimentin gene. J Natl Cancer Inst 2005;97:1124-1132 (Pubitemid 41511211)
34. Wang DR, Tang D. Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening. World J Gastroenterol 2008;14:524-531
35. Zhang W, Bauer M, Croner RS, et al. DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene. Dis Colon Rectum 2007;50:1618-26; discussion 1626-11617 (Pubitemid 47583343)
36. Huang Z, Li L, Wang J. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions. Dig Dis Sci 2007;52:2287-2291 (Pubitemid 47246528)
37. Oberwalder M, Zitt M, Wontner C, et al. SFRP2 methylation in fecal DNA - a marker for colorectal polyps. Int J Colorectal Dis 2008;23:15-19 (Pubitemid 350142355)
38. Muller HM, Oberwalder M, Fiegl H, et al. Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet 2004;363:1283-1285
39. Petko Z, Ghiassi M, Shuber A, et al. Aberrantly methylated CDKN2A, MGMT, MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res 2005;11:1203-1209 (Pubitemid 40175772)